Loading...

CDCA8, targeted by MYBL2, promotes malignant progression and olaparib insensitivity in ovarian cancer

Ovarian cancer is the most lethal gynecologic malignancy. Poly (ADP-ribose) polymerase inhibitors (PARPi) are effective in treating ovarian cancer. However, cancer cell insensitivity and resistance remain challenges. Determination of the exact chemoresistance mechanisms and potential targeted therap...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Am J Cancer Res
Main Authors: Qi, Gonghua, Zhang, Chenyi, Ma, Hanlin, Li, Yingwei, Peng, Jiali, Chen, Jingying, Kong, Beihua
Format: Artigo
Sprog:Inglês
Udgivet: e-Century Publishing Corporation 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7868764/
https://ncbi.nlm.nih.gov/pubmed/33575078
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!